Capitol Health Ltd (“CAJ”) – Healthcare upside!

[NZSilver]

was tempted pre HY results but though to much uncertainty. HY results confirm things at CAJ are a lot more unwell than the patients they have been putting through the MRI scanners unnecessarily and getting rebates from the aus govt. Staying well away at this stage, I still like healthcare but I think GLH has a lot more upside to offer.

[macduffy]

This, yesterday, from an un-named source:

"radiology group Capitol Health is in the crosshairs of Perth-based venture capital and private equity firm Viburnum Funds after the company's shares cratered in the wake of government intervention into the sector and a string of poor earnings results.

It is understood Viburnum has run the numbers on the business although it's unclear whether the investor intends to have a tilt at Capitol or acquire a large foothold on the register and militate as an activist investor.

Capitol Health's precipitous share price slide over the past year has rendered it low-hanging fruit for prospective predators. Since the stock hit a peak of $1.09 in April 2015, its shares have tumbled to 14c, reducing its market cap to $73m.

However, its takeover appeal is likely to be hampered by a near $100m debt load, amassed chiefly to fund the acquisitions of imaging centres."

FWIW.

[Joshuatree]

I had a multi bag run with CAJ but lazily bought back in to a small parcel in the 50's.That was a mistake and in my portfolio cleanup I've sold the remnants today. Like the health and bio sector still though.

[stoploss]

Not sure if anyone is still in , looks like the dark days are over ....

http://www.asx.com.au/asxpdf/2017061...mvx298yxj0.pdf

[ScrappyO]

Not sure if anyone is still in , looks like the dark days are over ....

http://www.asx.com.au/asxpdf/2017061...mvx298yxj0.pdf

Slowly Ticking over in the right direction. Results tomorrow.

[ScrappyO]

FY21 highlights and commentary
 Increase in Revenue to $178.0m vs pcp of $153.8m representing an increase of 15.7% (+$24.2m)
 Increase in statutory EBITDA to $44.2m vs pcp of $32.0m (+$12.2m or 38.1%)
 Increase in NPAT to $12.0m vs pcp of $1.1m (+$11.0m or 1005.6%)
 Final dividend payment maintained at 0.5 cps fully franked
 Increase in net cash from Operations of 16.8% to $40.9m
 Revaluation of Enlitic investment decreasing holding value by $2.6m
 Increase in EPS (basic) to 1.17 cps (up from 0.11 cps vs pcp)
 Net Debt/Operating EBITDA 0.2x